Not logged in Share Save
Current Ovarian Cancer Maintenance Strategies and Promising New Developments Gogineni, Vinaya; Morand, Susan; Staats, Hannah; Royfman, Rachel; Devanaboyina, Monika; Einloth, Katelyn; Dever, Danielle; Stanbery, Laura; Aaron, Phylicia; Manning, Luisa; Walter, Adam; Edelman, Gerald; Dworkin, Lance; Nemunaitis, John Share Save
Share Save
Share Save
Share Save
A phase I dose-escalation study of the safety and pharmacokinetics of a tablet formulation of voxtalisib, a phosphoinositide 3-kinase inhibitor, in patients with solid tumors Mehnert, Janice M.; Edelman, Gerald; Stein, Mark; Camisa, Heather; Lager, Joanne; Dedieu, Jean-Francois; Ghuysen, Anne-Frederique; Sharma, Jyoti; Liu, Li; LoRusso, Patricia M. Share Save
Share Save
Share Save
Phase I study of XL281 (BMS-908662), a potent oral RAF kinase inhibitor, in patients with advanced solid tumors Dickson, Mark A.; Gordon, Michael S.; Edelman, Gerald; Bendell, Johanna C.; Kudchadkar, Ragini R.; LoRusso, Patricia M.; Johnston, Stuart H.; Clary, Douglas O.; Schwartz, Gary K. Share Save
Share Save
Phase I Safety, Pharmacokinetic, and Pharmacodynamic Study of SAR245408 (XL147), an Oral Pan-Class I PI3K Inhibitor, in Patients with Advanced Solid Tumors Shapiro, Geoffrey I.; Rodon, Jordi; Bedell, Cynthia; Kwak, Eunice L.; Baselga, Jose; Brana, Irene; Pandya, Shuchi S.; Scheffold, Christian; Laird, A. Douglas; Nguyen, Linh T.; Xu, Yi; Egile, Coumaran; Edelman, Gerald Share Save
Phase I Study of a Systemically Delivered p53 Nanoparticle in Advanced Solid Tumors Senzer, Neil; Nemunaitis, John; Nemunaitis, Derek; Bedell, Cynthia; Edelman, Gerald; Barve, Minal; Nunan, Robert; Pirollo, Kathleen F.; Rait, Antonina; Chang, Esther H. Share Save
Share Save
Share Save
Share Save
Share Save
Share Save
Share Save
Share Save
Share Save